A Phase 2a Multicenter Open Label Single Arm Study Evaluating the Effect of ALLN-177 to Reduce Urinary Oxalate Excretion in Recurrent Idiopathic Calcium Oxalate Kidney Stone Formers with Hyperoxaluria
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to learn more about the effect of an investigational drug called ALLN-177.
Description
The purpose of this Phase II study is to see if ALLN-177 will reduce the occurrence of stone events in subjects with a history idiopathic calcium stones and hyperoxaluria.
Details
| Condition | hyperoxaluria |
|---|---|
| Age | 18years - 66years |
| Clinical Study Identifier | TX4177 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.